Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC)‎ and Triple-Negative Breast Cancer (TNBC)‎

المؤلفون المشاركون

Sheng, Iris Y.
Kruse, Megan
Leininger, Kathryn M.
Ornstein, Moshe C.

المصدر

Case Reports in Oncological Medicine

العدد

المجلد 2019، العدد 2019 (31 ديسمبر/كانون الأول 2019)، ص ص. 1-2، 2ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2019-06-04

دولة النشر

مصر

عدد الصفحات

2

التخصصات الرئيسية

الطب البشري

الملخص EN

Synchronous tumors are defined as two tumors arising concurrently or within six months of each other.

Reports of synchronous RCC and breast cancer are limited to nonmetastatic renal cell carcinoma (RCC) and hormone receptor-positive infiltrative ductal carcinoma.

We present the first case of synchronous metastatic renal cell carcinoma and metastatic triple-negative breast cancer, managed with a novel combination of immunotherapy and chemotherapy.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Sheng, Iris Y.& Kruse, Megan& Leininger, Kathryn M.& Ornstein, Moshe C.. 2019. Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC). Case Reports in Oncological Medicine،Vol. 2019, no. 2019, pp.1-2.
https://search.emarefa.net/detail/BIM-1142040

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Sheng, Iris Y.…[et al.]. Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC). Case Reports in Oncological Medicine No. 2019 (2019), pp.1-2.
https://search.emarefa.net/detail/BIM-1142040

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Sheng, Iris Y.& Kruse, Megan& Leininger, Kathryn M.& Ornstein, Moshe C.. Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC). Case Reports in Oncological Medicine. 2019. Vol. 2019, no. 2019, pp.1-2.
https://search.emarefa.net/detail/BIM-1142040

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1142040